Identification and verification of transthyretin as a potential biomarker for pancreatic ductal adenocarcinoma

Discovery of diagnostic biomarkers for pancreatic cancer in immunodepleted serum by SELDI-TOF MS

(2013) Aiqun Xue et al.   PANCREATOLOGY

α-Synuclein aggregation in the saliva of familial transthyretin amyloidosis: a potential biomarker

(2012) Ana Guerreiro et al.   AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS

Is there a role for the quantification of RRM1 and ERCC1 expression in pancreatic ductal adenocarcinoma?

(2012) Matias E Valsecchi et al.   BMC CANCER

A combination of serum leucine-rich α-2-glycoprotein 1, CA19-9 and interleukin-6 differentiate biliary tract cancer from benign biliary strictures

(2011) N S Sandanayake et al.   BRITISH JOURNAL OF CANCER

Protein Alterations Associated with Pancreatic Cancer and Chronic Pancreatitis Found in Human Plasma using Global Quantitative Proteomics Profiling

(2011) Sheng Pan et al.   JOURNAL OF PROTEOME RESEARCH

Pancreatic cancer

(2011) Audrey Vincent et al.   LANCET

Mass spectrometric immunoassay for quantitative determination of transthyretin and its variants

(2011) Olgica Trenchevska et al.   PROTEOMICS

Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis

(2010) A Xue et al.   BRITISH JOURNAL OF CANCER

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Transthyretin, identified by proteomics, is overabundant in pancreatic juice from pancreatic carcinoma and originates from pancreatic islets

(2010) Shunli Lv et al.   DIAGNOSTIC CYTOPATHOLOGY

Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview

(2010) S. Bünger et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

The immunohistochemical overexpression of ribonucleotide reductase regulatory subunit M1 (RRM1) protein is a predictor of shorter survival to gemcitabine-based chemotherapy in advanced non-small cell lung cancer (NSCLC)

(2010) Jae Jin Lee et al.   LUNG CANCER

Advanced pancreatic carcinoma: current treatment and future challenges

(2010) Anastasios Stathis et al.   Nature Reviews Clinical Oncology

VKORC1 Pharmacogenetics and Pharmacoproteomics in Patients on Warfarin Anticoagulant Therapy: Transthyretin Precursor as a Potential Biomarker

(2010) Ramasamy Saminathan et al.   PLoS One

Substrate specificity of transthyretin: identification of natural substrates in the nervous system

(2009) Márcia A. Liz et al.   BIOCHEMICAL JOURNAL

Serum Peptidome Profiling Revealed Platelet Factor 4 as a Potential Discriminating Peptide Associated with Pancreatic Cancer

(2009) G. M. Fiedler et al.   CLINICAL CANCER RESEARCH

Transthyretin as a potential CSF biomarker for Alzheimer’s disease and dementia with Lewy bodies: effects of treatment with cholinesterase inhibitors

(2009) K. Schultz et al.   EUROPEAN JOURNAL OF NEUROLOGY

A Compendium of Potential Biomarkers of Pancreatic Cancer

(2009) H. C. Harsha et al.   PLOS MEDICINE

Proteomic analysis of conditioned media from glucose responsive and glucose non-responsive phenotypes reveals a panel of secreted proteins associated with beta cell dysfunction

(2008) Paul Dowling et al.   ELECTROPHORESIS

Confounding Effect of Obstructive Jaundice in the Interpretation of Proteomic Plasma Profiling Data for Pancreatic Cancer

(2008) Li Yan et al.   JOURNAL OF PROTEOME RESEARCH

Transthyretin Protects against A-Beta Peptide Toxicity by Proteolytic Cleavage of the Peptide: A Mechanism Sensitive to the Kunitz Protease Inhibitor

(2008) Rita Costa et al.   PLoS One